Insulin Lispro vs Plecanatide
Head-to-head comparison of Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) and Plecanatide (Plecanatide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Insulin Lispro | Plecanatide |
|---|---|---|
| Category | Diabetes & Metabolic | Gastrointestinal |
| Full Name | Insulin lispro (B28-Lys, B29-Pro human insulin analog) | Plecanatide |
| Molecular Weight | 5808.0 Da | Approx. 1620 Da |
| Half-Life | About 1 hour | Local intestinal action; systemic half-life not clinically meaningful |
| Amino Acids | 51 | 16 |
| Typical Dose | 0.05-0.2 U/kg per meal | 3 mg once daily |
| Route | Subcutaneous | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 12000 | 350 |
| Research Status | Approved | Clinical |
Insulin Lispro Benefits
- ✓Rapid postprandial glucose control
- ✓Flexible premeal timing
- ✓Predictable onset of action
- ✓Useful in basal-bolus regimens
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Insulin Lispro Dosing
Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Insulin Lispro Side Effects
- ⚠Hypoglycemia
- ⚠Weight gain
- ⚠Injection-site reactions
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Research Overview
Insulin Lispro
Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.